Measuring adherence to highly active antiretroviral therapy: Implications for research and practice
- 1 December 2005
- journal article
- review article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 2 (4) , 200-205
- https://doi.org/10.1007/s11904-005-0017-3
Abstract
Highly active antiretroviral therapy (HAART) has radically changed the course of HIV disease, producing substantial reductions in both HIV-related morbidity and mortality. However, the complexity of the typical daily HAART regimen is substantial, and high levels of adherence are essential for complete and long-term viral suppression and the avoidance of drug resistance. The complexity of HAART has made the assessment of medication adherence of paramount importance. Even though various methods are in use, each measures only a subset of adherence behaviors, and each measure has limited predictive validity. Given the individual and public health concerns associated with adherence to HAART, there is a need for the continued development and validation of measures of medication adherence.Keywords
This publication has 53 references indexed in Scilit:
- Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherenceJournal of Clinical Epidemiology, 2001
- Misattribution, false recognition and the sins of memoryPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- Memory for memoryMemory & Cognition, 2001
- Measuring Adherence to Antiretroviral Medications in Clinical TrialsHIV Research & Clinical Practice, 2000
- Measuring medication adherence: is assessment of missed doses sufficient?AIDS, 1999
- Self-reports: How the questions shape the answers.American Psychologist, 1999
- The seven sins of memory: Insights from psychology and cognitive neuroscience.American Psychologist, 1999
- Counselling gay men with multiple loss and survival problems: The bereavement group as a transitional objectAIDS Care, 1998
- Transmission of Human Immunodeficiency Virus Type 1 Resistant to Nevirapine and ZidovudineThe Journal of Infectious Diseases, 1997
- A Dialectic on Validity: Where We Have Been and Where We Are GoingThe Journal of General Psychology, 1996